Testa C et al
How do I know if a medication is covered
Larger trials are ongoing, and a more comprehensive safety profile including the full spectrum of bowel-related effects will emerge as more data become available
Keep meals consistent when needed: some patients do better when they stop skipping meals, especially if cortisol or blood sugar is unstable
Your trajectory will be influenced by your starting weight, breastfeeding status, medication choice, dose, activity level, nutrition quality, hormonal recovery, and sleep patterns
Trial-Reported Endpoints by Phase Trial Lancet 2021 Phase 2 Duration 26 weeks Population Overweight/obese, no T2D (n=706) Mean Weight Loss 10.8% at 4.5 mg vs 3.0% placebo Trial Lancet 2023 Phase 2 Duration 32 weeks Population T2D + obesity (n=92) Mean Weight Loss 8.1% cagrilintide alone